Hong Kong Pharma Digital Technology Co. Ltd. (HKPD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hong Kong Pharma Digital Technology Co. Ltd. (HKPD:NASDAQ), powered by AI.

Current Price
$0.33
P/E Ratio
-125.5
Market Cap
3M
Sector
Healthcare
What is the Hong Kong Pharma Digital Technology Co. Ltd. stock price forecast?

Hong Kong Pharma Digital Technology Co. Ltd. is currently trading at $0.33. View real-time AI analysis on Alpha Lenz.

What is Hong Kong Pharma Digital Technology Co. Ltd. insider trading activity?

View the latest insider trading data for Hong Kong Pharma Digital Technology Co. Ltd. on Alpha Lenz.

What is Hong Kong Pharma Digital Technology Co. Ltd.'s P/E ratio?

Hong Kong Pharma Digital Technology Co. Ltd.'s P/E ratio is -125.5.

Hong Kong Pharma Digital Technology Co. Ltd.

NASDAQ · HKPD
$0.33-0.16(-31.98%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Hong Kong Pharma Digital Technology Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Hong Kong Pharma Digital Technology Co. Ltd. trades at a P/E of -125.5 (undervalued) with modest ROE of -0.6%.

Ask for details

Company Overview

Hong Kong Pharma Digital Technology Co. Ltd. is a distinguished enterprise at the intersection of pharmaceutical innovation and digital technology. The company primarily focuses on leveraging advanced digital technologies to enhance pharmaceutical development and healthcare solutions. Its initiatives include integrating data analytics and software platforms to optimize drug discovery processes, improve patient care, and streamline healthcare management. As part of the broader pharmaceutical and healthcare sectors, Hong Kong Pharma Digital Technology plays a crucial role in bridging traditional medicine with cutting-edge technology, thereby driving efficiency and efficacy in healthcare delivery. In the context of market significance, the company's digital approach positions it as a transformative player in the industry, appealing to investors interested in the convergence of technology and healthcare. This integration supports innovation and adaptation in rapidly evolving global health landscapes, underscoring the firm’s potential impact on both local and international scales.

CEOMr. Chenyu Liang
SectorHealthcare
IndustryPharmaceutical Retailers
Employees27

Company Statistics

FY 2025

Profile

$3.39MMarket Cap
$20.31MRevenue
0.00Shares Out
27Employees

Margins

11.89%Gross
6.23%EBITDA
0.99%Operating
0.18%Pre-Tax
-0.13%Net

Valuation

-125.46P/E
0.68P/B
0.17EV/Sales
3.97EV/EBITDA
8.19P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.30%ROA
-0.59%ROE
1.48%ROIC

Financial Health

$748.72KCash & Cash Equivalents
$3.68MNet Debt
88.73%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Hong Kong Pharma Digital Technology Co. Ltd. (ticker: HKPD) is a company listed on NASDAQ in the Healthcare sector (Pharmaceutical Retailers). It has approximately 27 employees. Market cap is $3M.

The current price is $0.333 with a P/E ratio of -125.46x and P/B of 0.68x.

ROE is -0.59% and operating margin is 0.99%. Annual revenue is $20M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Hong Kong Pharma Digital Technology Co. Ltd. (HKPD) Stock Forecast 2026 $0.33 — Price, Financials & Analyst Targets | Alpha Lenz